Comment on: "Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence".
- Published in:
- 2014
- By:
- Publication type:
- Letter
Works matching IS 11727047 AND DT 2014 AND VI 28 AND IP 12
Results: 11
1
2
Drug-Induced Cerebellar Ataxia: A Systematic Review.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1139, doi. 10.1007/s40263-014-0200-4
- By:
- Publication type:
- Article
3
Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1155, doi. 10.1007/s40263-014-0205-z
- By:
- Publication type:
- Article
4
Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1103, doi. 10.1007/s40263-014-0208-9
- By:
- Publication type:
- Article
5
Methamphetamine Psychosis: Epidemiology and Management.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1115, doi. 10.1007/s40263-014-0209-8
- By:
- Publication type:
- Article
6
Comment on: 'Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence'.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1205, doi. 10.1007/s40263-014-0211-1
- By:
- Publication type:
- Article
7
Authors' Reply to Whitlock: Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1207, doi. 10.1007/s40263-014-0212-0
- By:
- Publication type:
- Article
8
A Single-Dose Pilot Trial of Intranasal Rapid-Acting Insulin in Apolipoprotein E4 Carriers with Mild-Moderate Alzheimer's Disease.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1185, doi. 10.1007/s40263-014-0214-y
- By:
- Publication type:
- Article
9
Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1127, doi. 10.1007/s40263-014-0215-x
- By:
- Publication type:
- Article
10
Acknowledgement to Referees.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1099, doi. 10.1007/s40263-014-0218-7
- Publication type:
- Article
11
Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
- Published in:
- CNS Drugs, 2014, v. 28, n. 12, p. 1191, doi. 10.1007/s40263-014-0193-z
- By:
- Publication type:
- Article